ng-nitroarginine methyl ester has been researched along with Carcinoma, Epidermoid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashitani, S; Kishimoto, H; Noguchi, K; Ohtsu, N; Segawa, E; Takaoka, K; Urade, M | 1 |
| Chen, WL; Li, HG; Li, JS; Wang, JG; Yang, ZH | 1 |
| Chen, YK; Huse, SS; Lin, LM | 1 |
| Li, JR; Li, ZB; Shang, ZJ | 1 |
| Fini-Storchi, I; Franchi, A; Gallo, O; Masini, E; Morbidelli, L; Vergari, WA; Ziche, M | 1 |
| Hess, A; Michel, O; Watanabe, K; Yagi, T | 1 |
6 other study(ies) available for ng-nitroarginine methyl ester and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; KB Cells; Mice; Mice, Inbred BALB C; Mice, Nude; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrazoles; Sulfonamides; Up-Regulation; Xenograft Model Antitumor Assays | 2010 |
[Intervention effect of an inducible nitric oxide synthase inhibitor on carcinogenesis of hamster cheek pouch carcinoma].
Topics: Animals; Carcinoma, Squamous Cell; Cricetinae; Enzyme Inhibitors; Mesocricetus; Mouth Neoplasms; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Vascular Endothelial Growth Factor A | 2004 |
Inhibitory effect of inducible nitric oxide synthase inhibitors on DMBA-induced hamster buccal-pouch squamous-cell carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cricetinae; Enzyme Inhibitors; Guanidines; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II | 2005 |
In vitro effects of nitric oxide synthase inhibitor L-NAME on oral squamous cell carcinoma: a preliminary study.
Topics: Acridine Orange; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Coloring Agents; DNA; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Enzyme Inhibitors; Fluorescent Dyes; Gentian Violet; Humans; In Situ Hybridization; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrous Oxide; RNA; Tetrazolium Salts; Thiazoles; Tongue Neoplasms; Tumor Cells, Cultured | 2006 |
Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cyclic GMP; Disease Progression; Enzyme Inhibitors; Female; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Transcription, Genetic; Tumor Cells, Cultured | 1998 |
Nitric oxide synthase inhibitor reduces the apoptotic change in the cisplatin-treated cochlea of guinea pigs.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cisplatin; Cochlea; DNA Fragmentation; DNA, Single-Stranded; Enzyme Inhibitors; Guinea Pigs; Immunohistochemistry; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase | 2000 |